Biological
BRII-179 clinical trials
Also written BRII-179.
- studies test it
- 3
- open now
- 1
- in phase 3
- 0
- first study started
- 2021
Keep track of what changes. Save the BRII-179 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Brii Biosciences Limited (3)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses BRII-179 is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)RecruitingPhase 2Brii Biosciences LimitedNCT06650852Written as BRII-179
- Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)CompletedPhase 2Brii Biosciences LimitedNCT06491563Written as BRII-179
- Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) InfectionCompletedPhase 2Brii Biosciences LimitedNCT04749368Written as BRII-179 (VBI-2601)